Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bbddfcf3cdb657c5d7f8c6fc9d164cc64> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bbddfcf3cdb657c5d7f8c6fc9d164cc64 NCIT_P378 "NCI" @default.
- Bbddfcf3cdb657c5d7f8c6fc9d164cc64 type Axiom @default.
- Bbddfcf3cdb657c5d7f8c6fc9d164cc64 annotatedProperty IAO_0000115 @default.
- Bbddfcf3cdb657c5d7f8c6fc9d164cc64 annotatedSource NCIT_C148402 @default.
- Bbddfcf3cdb657c5d7f8c6fc9d164cc64 annotatedTarget "A cancer vaccine consisting of a recombinant fowlpox viral (FPV) vector encoding the human transcription factor and tumor-associated antigen (TAA) brachyury, and a triad of T-cell co-stimulatory molecules (TRICOM), which is comprised of the three human immune-enhancing co-stimulatory molecules B7-1, ICAM-1 and LFA-3, with potential immunostimulatory and antineoplastic activities. Upon subcutaneous administration occurring after the administration of a proprietary modified vaccinia Ankara developed by Bavarian Nordic-based prime vaccine (MVA-BN-brachyury), the booster vaccine FPV-brachyury vaccine potentiates a cytotoxic T-lymphocyte (CTL) response against brachyury-expressing tumor cells. The expression of brachyury, a member of the T-box family of transcription factors that is overexpressed in numerous cancer cell types, is correlated with increased epithelial-mesenchymal transition (EMT), cancer resistance, cancer progression and metastasis. TRICOM enhances antigen-specific T-cell activation." @default.